Jaya Janadhyala (@jayamj94) profile picture

Jaya Janadhyala

@jayamj94

CV Fellow @CooperCVFellows 🫀 | IM Residency at @TJUHospital | Medical College of Georgia Class of 2020

Joined July 2022
  • Tweets9
  • Following45
  • Followers85
How do you relate the parameters and hemodynamics of continuous-flow left ventricular assist devices (LVAD)? Here's a🧵 that seeks to answer this question for trainees on their CHF rotation Special thanks to @AHajduczok and @gregorytgibson for their help with this topic
2
30
2
72
23,650
Excited to share Part II of the Basics of PV loops that I worked on with @AHajduczok and @PSullivan000
Alexander Hajduczok, MD 🇺🇦🙏 (@AHajduczok) profile pictureAlexander Hajduczok, MD 🇺🇦🙏
@AHajduczok30 Mar 2023
Part II of the Basics of PV loops: preload, coupling, afterload, ventricular dysfunction, and valvular disorders. Big thanks to the team who helped put this together: @jayamj94 & @PSullivan000, with guest editor @RyanTedfordMD. If you missed Part I, check it out ⬇️
1
2
12
3,033
Jaya Janadhyala retweeted
Salil Chowdhury (@SChowdhuryMD) profile picture
Salil Chowdhury@SChowdhuryMD14 Mar 2023
Excited to see our work published!
Journal of Immunological Sciences (@immunologyjour1) profile pictureJournal of Immunological Sciences@immunologyjour113 Mar 2023
Poor Prognosis in HBV-associated Hepatocellular Carcinoma After Successful Viral Suppression: A Case Series Highlighting a Need for a Cure Read: immunologyresearchjournal.co… #HepatocellularCarcinoma #HepatitisBVirus #HBVAssociatedHCC #AntiviralTherapy #LiverTransplantation
The transverse ultrasound image (A) shows a hypoechoic, solid-appearing lesion in the liver (arrows). The fat-suppressed, T1-weighted postcontrast image from an MRI obtained weeks after the ultrasound (B) shows a left lobar mass (arrow). The more caudal image (C) demonstrates portal venous tumor thrombus associated with the mass and typical of hepatocellular carcinoma with tumor in the vein (TIV) (arrow).

ALT The transverse ultrasound image (A) shows a hypoechoic, solid-appearing lesion in the liver (arrows). The fat-suppressed, T1-weighted postcontrast image from an MRI obtained weeks after the ultrasound (B) shows a left lobar mass (arrow). The more caudal image (C) demonstrates portal venous tumor thrombus associated with the mass and typical of hepatocellular carcinoma with tumor in the vein (TIV) (arrow).

The axial fat-suppressed, T1-weighted arterial phase postcontrast image (A) shows an approximately 2cm hypointense lesion in segment 4B that demonstrates heterogeneous hyperenhancement (arrow). The ultrasound image following microwave ablation (B) shows increased echogenicity within the treated lesion (arrow) indicating treatment effects. The subsequent fat-suppressed, T1-weighted postcontrast arterial phase image (C) shows an approximately 4cm hyperenhancing LI-RADS 5 lesion (arrow) confirming the diagnosis of HCC. An axial maximal intensity projection (MIP) image (D) from a subsequent chest CT shows numerous pulmonary nodules (arrows) typical of metastases.

ALT The axial fat-suppressed, T1-weighted arterial phase postcontrast image (A) shows an approximately 2cm hypointense lesion in segment 4B that demonstrates heterogeneous hyperenhancement (arrow). The ultrasound image following microwave ablation (B) shows increased echogenicity within the treated lesion (arrow) indicating treatment effects. The subsequent fat-suppressed, T1-weighted postcontrast arterial phase image (C) shows an approximately 4cm hyperenhancing LI-RADS 5 lesion (arrow) confirming the diagnosis of HCC. An axial maximal intensity projection (MIP) image (D) from a subsequent chest CT shows numerous pulmonary nodules (arrows) typical of metastases.

The axial fat-suppressed, T1-weighted postcontrast image (A) shows a 2cm heterogeneously hyperenhancing lesion in segment 5 (arrow). Over 3 years following transarterial chemoembolization (TACE), on the fat-suppressed, T1-weighted postcontrast image (B) the treated lesion (arrow) exhibits heterogeneous signal corresponding to posttreatment changes, although there is focal hyperenhancement adjacent to the treated lesion (thick arrow). The axial fat-suppressed, T1-weighted postcontrast image (C) obtained 14 years following repeat TACE and microwave ablation shows absent enhancement in the treated area in segment 5 (arrow) with a new hyperenhancing lesion in segment 3 (thick arrow).

ALT The axial fat-suppressed, T1-weighted postcontrast image (A) shows a 2cm heterogeneously hyperenhancing lesion in segment 5 (arrow). Over 3 years following transarterial chemoembolization (TACE), on the fat-suppressed, T1-weighted postcontrast image (B) the treated lesion (arrow) exhibits heterogeneous signal corresponding to posttreatment changes, although there is focal hyperenhancement adjacent to the treated lesion (thick arrow). The axial fat-suppressed, T1-weighted postcontrast image (C) obtained 14 years following repeat TACE and microwave ablation shows absent enhancement in the treated area in segment 5 (arrow) with a new hyperenhancing lesion in segment 3 (thick arrow).

The axial fat-suppressed, T1-weighted delayed postcontrast image (A) shows a small hepatic segment 8 lesion exhibiting washout (arrow) and corresponding to a small HCC. The axial fat-suppressed, T1-weighted arterial phase postcontrast image obtained 11 years later (B) shows a 3cm hyperenhancing lesion (arrow) in segment 5 adjacent to the gallbladder (thick arrow) indicating recurrent HCC. On a more cephalad arterial phase image (C), a second hyperenhancing HCC (arrow) in segment 7 is evident. Four years later, the fat-suppressed, T1-weighted arterial phase postcontrast image (D) shows yet another large, hyperenhancing segment 4 lesion (arrow) consistent with HCC.

ALT The axial fat-suppressed, T1-weighted delayed postcontrast image (A) shows a small hepatic segment 8 lesion exhibiting washout (arrow) and corresponding to a small HCC. The axial fat-suppressed, T1-weighted arterial phase postcontrast image obtained 11 years later (B) shows a 3cm hyperenhancing lesion (arrow) in segment 5 adjacent to the gallbladder (thick arrow) indicating recurrent HCC. On a more cephalad arterial phase image (C), a second hyperenhancing HCC (arrow) in segment 7 is evident. Four years later, the fat-suppressed, T1-weighted arterial phase postcontrast image (D) shows yet another large, hyperenhancing segment 4 lesion (arrow) consistent with HCC.

3
15
3,147
When @EugeneStorozyn6 has to step away from CCU rounds for a RHC - perfect time to let senior resident and future @CooperCVFellows cards fellow @jayamj94 lead a chalk talk primer on hemodynamics in the CCU… you may recall our recent #tweetorial on PV loops (below ⬇️). 🫀📈👌🏼
Image from Alexander Hajduczok, MD 🇺🇦🙏 (@AHajduczok)
1
7
25
6,046
Super excited to be joining @CooperCVFellows for cardiology fellowship! 🫀
Joanne Mazzarelli, MD (@MazzJk) profile pictureJoanne Mazzarelli, MD@MazzJk1 Dec 2022
Congratulations to all of the CV applicants this season. We are very excited welcome our new class of CV fellows at Cooper University Hospital. We can’t wait to work with you ! @CooperCVFellows @VivekKulkarniMD @CooperIMRes @coopermedschool @
Image from Joanne Mazzarelli, MD (@MazzJk)
1
21
Excited to share Part 1 of a series on PV Loops I worked on with @AHajduczok and @PSullivan000. Definitely enjoyed this project and hope it helps lay out a good foundation for PV Loops and hemodynamics. Stay tuned for more!
Alexander Hajduczok, MD 🇺🇦🙏 (@AHajduczok) profile pictureAlexander Hajduczok, MD 🇺🇦🙏
@AHajduczok21 Oct 2022
Do you ❤️ hemodynamics? How about PV loops? Here is Part I of our journey to to help YOU better understand PV loops and make them a little less daunting. Couldn't have done this without ⭐ @TJUHospital resident @jayamj94, and edits from @PSullivan000. Stay tuned for Part 2!
Image from Alexander Hajduczok, MD 🇺🇦🙏 (@AHajduczok)
1
4
1
14
Last but certainly not least - PV loop review. "You can never spend enough time reviewing PV loops" - @YevgeniyBr, probably Stay tuned for a tweetorial on this topic... @jayamj94 @PSullivan000 @IRajapreyar @gregorytgibson @EugeneStorozyn6 @DavidWienerMD
Image from Jefferson Cardiology Fellows (@TJHeartFellows)
Image from Jefferson Cardiology Fellows (@TJHeartFellows)
2
1
12
Good luck to the @TJUHospital IM residents applying for cards fellowship. Been a pleasure working with all of you in the CCU and w/ research. Programs will be lucky to have you!! Highlights below… @max_ruge_md @SSchneiderMD @Matt_DiMeglio @KirpalKocharMD @JunartaMD @jayamj94 – at Philadelphia, PA
Image from Alexander Hajduczok, MD 🇺🇦🙏 (@AHajduczok)
1
10
38
Load more